Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Riad D Dirani
Observed names:
R Dirani,
R. Dirani,
Riad Dirani
Institution:
Janssen Scientific Affairs (United States)
Observed institutions:
Northwestern University,
Pennsylvania State University,
Duke University,
Pfizer (United States),
University of Utah,
GlaxoSmithKline (United States),
Janssen Scientific Affairs (United States),
Janssen Research & Development (United States),
Thomson Reuters (United States)
show all 9
OpenAlex ID:
A5110085967
Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking
2006
·
Lisa Mucha
, Judith Stephenson
, et al.
·
Gender Medicine
·
208
Effect of Smoking Status on Productivity Loss
2006
·
William B. Bunn
, Gregg M. Stave
, et al.
·
Journal of Occupational and Environmental Medicine
·
153
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population
2008
·
Joseph Menzin
, Luke Boulanger
, et al.
·
Respiratory Medicine
·
123
Medication Adherence and Hospitalization Among Patients With Schizophrenia Treated With Antipsychotics
2010
·
K. Lang
, J. L. Meyers
, et al.
·
Psychiatric Services
·
114
Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients
2010
·
Margaret K. Vernon
, Dennis A. Revicki
, et al.
·
Schizophrenia Research
·
93
The Use of Health Care Services by People With Diabetes in Rural Areas
1998
·
Kathryn H. Dansky
, Riad Dirani
·
The Journal of Rural Health
·
74
Adherence to oral second‐generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
2012
·
J. J. Stephenson
, O. Tuncelli
, et al.
·
International Journal of Clinical Practice
·
65
PDF
Prevalence of liver disease in veterans with bipolar disorder or schizophrenia
2011
·
Bret E. Fuller
, Veronica L. Rodriguez
, et al.
·
General Hospital Psychiatry
·
63
PDF
Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia
2014
·
Marie-Hélène Lafeuille
, Jason Dean
, et al.
·
Current Medical Research and Opinion
·
55
Profiles of Hospital, Physician, and Home Health Service Use by Older Persons in Rural Areas
1998
·
K. H. Dansky
, D. Brannon
, et al.
·
The Gerontologist
·
54
Workplace productivity, employment issues, and resource utilization in patients with bipolar I disorder
2009
·
Barbara J. McMorris
, Kristen E. Downs
, et al.
·
Journal of Medical Economics
·
47
Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
2011
·
Tim Lambert
, José M Olivares
, et al.
·
Annals of General Psychiatry
·
45
PDF
An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation
2007
·
Kenneth C. Jackson
, Robert Nahoopii
, et al.
·
Journal of Occupational and Environmental Medicine
·
44
Access to new medications to treat schizophrenia
2002
·
Tami L. Mark
, Riad Dirani
, et al.
·
The Journal of Behavioral Health Services & Research
·
43
Impacts of a Smoking Cessation Benefit Among Employed Populations
2007
·
Michael T. Halpern
, Riad Dirani
, et al.
·
Journal of Occupational and Environmental Medicine
·
42
Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE)
2011
·
Chris M. Kozma
, Terra Slaton
, et al.
·
Current Medical Research and Opinion
·
40
Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
2011
·
Wayne Macfadden
, Cherilyn DeSouza
, et al.
·
BMC Psychiatry
·
36
PDF
Indirect Costs Associated With Nonadherence to Treatment for Bipolar Disorder
2010
·
Erin Bagalman
, Kristina S. Yu-Isenberg
, et al.
·
Journal of Occupational and Environmental Medicine
·
36
Medicaid Cost Control Measures Aimed At Second-Generation Antipsychotics Led To Less Use Of All Antipsychotics
2011
·
William B. Vogt
, Geoffrey Joyce
, et al.
·
Health Affairs
·
35
One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia
2008
·
Natalie C. Edwards
, Jacqueline Pesa
, et al.
·
Current Medical Research and Opinion
·
33
Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia
2013
·
Jessica Panish
, Sudeep Karve
, et al.
·
Journal of Pharmaceutical Health Services Research
·
31
PDF
Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)
2011
·
Concetta Crivera
, Cherilyn DeSouza
, et al.
·
BMC Psychiatry
·
30
PDF
Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System
2009
·
M. Fuller
, K. Shermock
, et al.
·
Journal of Medical Economics
·
28
Pharmacotherapy patterns in the treatment of bipolar disorder
2002
·
Patricia Russo
, Mark W Smith
, et al.
·
Bipolar Disorders
·
24
Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration
2010
·
X. S. Ren
, C. Crivera
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
20
Show more works
View as search
Works count:
59
Citation count:
1,688
H-index:
24
I10-index:
33
Year
Topic
Type